ISA Pharmaceuticals and Regeneron Announce Strategic Immuno-Oncology Collaboration Leiden, The Netherlands, December 18, 2017, -- ISA Pharmaceuticals B.V., a clinical-stage immunotherapy company, and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced a clinical...